Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
4.96
Nov 09 • 4:00 PM ET Dollar change+0.38 Percentage change(8.30%)
Aftermarket Close
4.96
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
1.40B
Enterprise Value
1.40B
Income
-0.00M
Sales
0.00M
Book/sh
7.23
Cash/sh
0.00
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
-
IPO
Apr 17, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.69
P/C
3878.92
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
0.08
Current Ratio
0.08
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-0.00
EPS next Y
-
EPS next Q
-0.16
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-100.10%
Sales Y/Y TTM
-
EPS Q/Q
-239.04%
Sales Q/Q
-
Insider Own
22.89%
Insider Trans
0.00%
Inst Own
114.80%
Inst Trans
0.12%
ROA
-0.00%
ROE
-0.00%
ROIC
-0.00%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
1.13%
SMA50
-32.42%
SMA200
-49.34%
Trades
Shs Outstand
20.91M
Shs Float
16.12M
52W High
11.60 -57.24%
52W Low
3.93 26.21%
Volatility
14.20% 13.42%
ATR (14)
0.61
RSI (14)
40.82
Beta
0.95
Rel Volume
0.34
Avg Volume
460.05K
Volume
157,874
Perf Week
12.98%
Perf Month
-33.60%
Perf Quarter
-53.34%
Perf Half Y
-52.94%
Perf YTD
-52.15%
Perf Year
-51.98%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
4.58
Price
4.96
Change %
8.30%
Analysts1incl. previous ratings
Rating Distribution0 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 19, 2026Initiated
BBTIG Research
Neutral
newcleo Plc engages in the development and deployment of a scalable nuclear energy platform. Its technology includes reactors, LFR-AS-30 project, Fuel, and MOX Fuel Fabrication project. The company was founded by Stefano Buono and Elisabeth Rizzotti on March 18, 2021 and is headquartered in London, the United Kingdom.
Co-FounderMr. Stefano Buono
Co-FounderMs. Elisabeth Rizzotti
Group Chief Financial OfficerMr. Jon Stranske
Chief Scientific OfficerMr. Luciano Cinotti
Investor Relations DirectorMs. Giulia De Benedetti